Loading clinical trials...
Loading clinical trials...
Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
NCT06953908 · Gender Identity, Gender Dysphoria, Adult, and more
NCT05318755 · Transgender, Gender Incongruence
NCT07128771 · Gender Incongruence, Cardiovascular Disease (CVD) Risk Factors
NCT06774053 · Transgender Individuals, Gender Incongruence
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse
University Medical Center Hamburg-Eppendorf
Hamburg
Medical Center of the Ludwig-Maximilians-University of Munich
Munich
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions